Document zdwXZ8op20V9kOa8g5pLgnjvn

From: Sent: To: Subject: Cagen, Stuart Z SCC Thursday, September 6,2001 5:29 PM (GMT) Clegg, Patsy M SCC-CHSE-PC <pmc1egg@Shel1.Com>; Tsai, Shan SP SHLOIL-SPS <sptsai@Shell.Com> FW: Financial oversight by Technical Committee FYI -----Original Message----From: Beatty, Patrick (PWBE) [SMTP:PWBE@chevron.com] Sent: Thursday, September 06,2001 12:24 PM To: 'Cagen, Stuart Z SCC' Subject: RE: Financial oversight by Technical Committee Stuart. Thanks for the reply. I think that there is merit in Shell's suggestion. I imagine that this may require a sit down meeting with the Technical Committee, the investigators and API financial staff to arrive at some mutually agreeable arrangement. Let's keep this in mind. Patrick > -----Original Message----> From: Cagen, Stuart Z SCC [SMTP:szcagen@SheII.Com] > Sent: Thursday, September 06,2001 9:52 AM > To: 'Beatty, Patrick (PWBE)' > Cc: Clegg, Patsy M SCC-CHSE-PC; Tsai, Shan SP SHLOIL-SPS; 'George > Woodall' > Subject: RE: Financial oversight by Technical Committee > > Pat: > > This message is sent on behalf of Shell, including Patsy (who cannot > respond > this week), Shan and myself. > > The idea to require semi-annual financial reporting (plus special > reporting > in conjunction with milestones) is a good one and is something we highly > support. However, we (Shell) would further recommend that we (the > consortium) should provide guidance to the investigators and their > institutions regarding the nature of this reporting. I don't have > specifics > to offer right now, but the financial reporting has to be meaningful. > This > means that we not only need to be able to understand it, we should also be > able to audit these financial reports in some rudimentary manner. > Today's > addition to your recommendation is that one of the committees - probably > the > technical committee - should take on an action to prepare a financial > reporting guidance document for the investigators by the end of the year. > SHELL-MCCLURG-051849 > > Thanks > > Stuart > > Stuart Cagen, Ph.D., Staff Toxicology Advisor > Shell Chemical Company, P.O. Box 4320, Houston, Texas 77210 > tel: 713-241-1407; fax: 713-241-3325; email: szcagen@shellus.com > mobile: 832-309-1984 > > > > > -----Original Message----> > From: Beatty, Patrick (PWBE) [SMTP:PWBE@chevron.com] > > Sent: Wednesday, September 05,2001 1:19 PM > > To: 'BenzConsort-OC@listserve.api.org'; > > 'BenzConsort-TC@listserve.api.org' > > Subject: FW: Financial oversight by Technical Committee > > Importance: High > > Let's try this again. > > > -----Original Message----> > > From: Beatty, Patrick (PWBE) > > > Sent: Wednesday, September 05,2001 11 :15 AM > > > To: 'BenzCnsort-OC@listserve.api.org'; > > > 'BanzConsort-TC@listserve.api.org' > > > Subject: FW: Financial oversight by Technical Committee > > > Importance: High > > > > All, > > > > One of the issues that will arise in the financial agreements with the > > > investigators will be the frequency with which there will be reports > > from > > > the investigators with respect to expenditures vs. progress. The > > > Oversight Committee has charged the Technical Committee with > developing a > > > series of research and financial milestones by which to track progress > > and > > > ensure that spending is not getting out of hand. This raises the > > question > > > of how often the contracts/grants should require reports. Obviously > > this > > > requires balancing a frequency of reporting that allows timely > > > notification of cost overruns but does not pose an undue burden on the > > > investigators. The contracts are being developed at this time and I > > > wanted to our two committees to provide some direction to API SHELL-MCCLURG-051850 > regarding > > > the timing of financial reporting by the investigators. > > > > I would like to suggest that we have formal financial reports on a > > > semiannual basis, e.g., January and July. One would be at the time > of > > > the annual project review meeting when presentations are made to the > > > consortium committees and the Review Panels. I think that this would > > > allow adequate matching of research milestones with projected > expenses. > > > In addition more informal reports could be obtained, for instance, > when > > > milestones are reached between reporting dates or when the University > of > > > Colorado makes payments to Fudan University. These could be simple > > > notifications which would not require significant effort by the > > > investigators. > > > > I would like to get feedback from both Technical and Oversight > > Committees > > > on this. Do you agree with the semiannual reporting? If not API will > > > have to renegotiate the contracts with U. Colorado. > > > > A slightly more complicated situation will arise with the contracts > > > directly between API and the Chinese for expenses for Otto Wong's > > portion > > > of the case control study. Otto does not have the administrative > > > structure to handle billing and reimbursement of the Chinese > > participants. > > > API will have contracts directly with Fudan University for those > items. > > > There may also be contracts with the CDC and IPHS. I think there Otto > > > will need to work with the API to coordinate payments with effort by > the > > > Chinese participants. I do not believe that development of those > > > contracts have been initiated yet. > > > > Patrick > > > > > Patrick W. Beatty Ph.D., D.A.B.T. > > > (510) 242-7037 Office; (510) 242-7022 FAX > > > Staff Toxicologist > > > Petroleum Team > > > Toxicology and Health Risk Assessment > > > CRTC RIC 100 Bldg. 24-1125 > > > E-mail: pwbe@chevron.com > SHELL-MCCLURG-051851